Gross Lesion Spatial Distribution of Prostate Cancer Confirmed by Transperineal Prostate Biopsy
-
摘要:
目的 探讨经会阴途径穿刺确诊的前列腺癌大体病理的病灶空间分布特点。 方法 北京协和医院2013年11月至2015年3月经会阴前列腺穿刺阳性且阳性区数≤ 6区的前列腺癌根治术后标本61例, 根据大体病理分为前、后半区为主肿瘤并比较肿瘤阳性率和肿瘤特点。进一步以尖部、中部和基底部为分区, 比较各部分的肿瘤分布情况。 结果 61个主要肿瘤中, 前半区为主肿瘤有32个(52.5%), 后半区为主肿瘤有29个(47.5%), 两者比较差异无统计学意义(χ2=0.295, P=0.587)。对于切缘阳性率和Gleason评分, 前半区为主肿瘤与后半区为主肿瘤相比较差异均无统计学意义。中部、尖部和基底部的肿瘤阳性率分别为96.7%、80.3%和29.5%, 平均单位体积肿瘤负荷分别为105.17、130.62和69.81 μl/ml。其中, 尖部与基底部相比有更高的肿瘤阳性率(χ2=31.816, P < 0.001)和单位体积肿瘤负荷(P=0.028)。 结论 经会阴前列腺穿刺阳性的前列腺癌大体病理前、后半区的肿瘤阳性率一致, 肿瘤特点相同。前列腺尖部比基底部有更高的肿瘤阳性率和单位体积肿瘤负荷。 Abstract:Objective To demonstrate the gross lesion spatial distribution of prostate cancer confirmed by template-guided transperineal prostate biopsy (TTPB). Methods This study enrolled 61 consecutive patients diagnosed as prostate cancer with no more than 6 positive regions on TTPB between November 2013 and March 2015 in Peking Union Medical College Hospital. With radical prostatectomy specimens from these patients, we compared the tumor frequencies and characteristics on anterior and posterior zones in gross pathology. The lesion spatial distributions were further compared among apex, middle, and base of prostate. Results Of the 61 predominant tumors, the anterior (APCs) and posterior prostate cancers (PPCs) were 32 (52.5%) and 29 (47.5%), with no significant difference (χ2=0.295, P=0.587). There was no difference in positive surgical margin or Gleason score (GS) between APCs and PPCs. The tumor frequencies of apex, middle, and base of prostate were 96.7%, 80.3%, and 29.5%, respectively; the tumor loads per unit volume were 105.17, 130.62, and 69.81 μl/ml, respectively. Compared with the base, the apex had a higher tumor frequency (χ2=31.816, P < 0.001) and tumor load (P=0.028). Conclusions The tumor frequencies and pathological characteristics observed in gross pathology of the anterior and posterior zones of whole-mounted radical prostatectomy specimens may be similar in TTPB-confirmed prostate cancer. Compared with the base of prostate, the apex may be associated with a higher tumor frequency and tumor load. -
Key words:
- prostate cancer /
- transperineal prostate biopsy /
- gross pathology /
- spatial distribution
-
表 1 前列腺癌根治术后标本中以前、后半区为主肿瘤比较
肿瘤位置 例数(%) 切缘阳性[例(%)] GS≤6(例) GS=3+4(例) GS=4+3(例) GS≥8(例) 前半区为主 32(52.5) 7(21.8) 4 19 6 3 后半区为主 29(47.5) 6(20.7) 6 14 5 4 χ2值 0.295 0.013 0.744 0.755 0.023 0.292 P值 0.587 0.910 0.388 0.385 0.878 0.589 GS:Gleason评分 表 2 前列腺癌根治术后标本中部、尖部和基底部肿瘤阳性率和单位体积肿瘤负荷比较
部位 阳性例数 阳性率(%) 单位体积肿瘤负荷(M,μl/ml) 中部 59 96.7 105.17(0.02~721.92) 尖部 49 80.3* 130.62(0.20~520.71) 基底部 18 29.5*†† 69.81(0.92~213.65)† 与中部比较,*P<0.01;与尖部比较,†P<0.05,††P<0.01 -
[1] Chang DT, Challacombe B, Lawrentschuk N. Transperineal biopsy of the prostate—is this the future?[J]. Nat Rev Urol, 2013, 10: 690-702. doi: 10.1038/nrurol.2013.195 [2] Mabjeesh NJ, Lidawi G, Chen J, et al. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy[J]. BJU Int, 2012, 110: 993-997. doi: 10.1111/j.1464-410X.2012.10972.x [3] Gershman B, Zietman AL, Feldman AS, et al. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies[J]. Urol Oncol, 2013, 31: 1093-1097. doi: 10.1016/j.urolonc.2012.01.001 [4] Matthew Andrews J, Ashfield JE, Morse M, et al. Five-year follow-up of active surveillance for prostate cancer: A Canadian community-based urological experience.[J]. Can Urol Assoc J, 2014, 8: 768-774. doi: 10.5489/cuaj.2186 [5] Barqawi AB, Stoimenova D, Krughoff K, et al. Targeted focal therapy for the management of organ confined prostate cancer[J]. J Urol, 2014, 192:749-753. doi: 10.1016/j.juro.2014.03.033 [6] Koppie TM, Bianco FJ Jr, Kuroiwa K, et al. The clinical features of anterior prostate cancers[J]. BJU Int, 2006, 98: 1167-1171. doi: 10.1111/j.1464-410X.2006.06578.x [7] 那彦群, 叶章群, 孙颖浩, 等.中国泌尿外科诊断治疗指南[M].北京:人民卫生出版社, 2014: 65. [8] Lemaitre L, Puech P, Poncelet E, et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings[J]. Eur Radiol, 2009, 19: 470-480. doi: 10.1007/s00330-008-1153-0 [9] Davis JW, Kim J, Ward JF, et al. Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analy-sis of volume and zonal distribution of tumour foci[J]. BJU Int, 2010, 105: 1386-1391. http://www.ncbi.nlm.nih.gov/pubmed/19888979/ [10] Richters A, Derks J, Husson O, et al. Effect of surgical margin status after radical prostatectomy on health-related quality of life and illness perception in patients with prostate cancer[J]. Urol Oncol, 2015, 33: 16.e9-15. doi: 10.1016/j.urolonc.2014.10.006 [11] McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread[J]. Am J Surg Pathol, 1988, 12: 897-906. doi: 10.1097/00000478-198812000-00001 [12] Chun FK, Epstein JI, Ficarra V, et al. Optimizing performance and interpretation of prostate biopsy a critical analysis of the literature[J]. Eur Urol, 2010, 58: 851-864. doi: 10.1016/j.eururo.2010.08.041 [13] Rabbani F, Stroumbakis N, Kava BR, et al. Incidence and clinical significance of false-negative sextant prostate biopsies[J]. J Urol, 1998, 159: 1247-1250. doi: 10.1016/S0022-5347(01)63574-2 [14] Epstein JI, Walsh PC, Sauvageot J, et al. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer[J]. J Urol, 1997, 158: 1886-1890. doi: 10.1016/S0022-5347(01)64159-4 [15] Bott SR, Young MP, Kellett MJ, et al. Anterior prostate cancer: is it more difficult to diagnose?[J].BJU Int, 2002, 89: 886-889. doi: 10.1046/j.1464-410X.2002.02796.x [16] Bouyé S, Potiron E, Puech P, et al. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology[J]. Prostate, 2009, 69: 105-113. doi: 10.1002/pros.20859 [17] Breslow N, Chan CW, Dhom G, et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France[J]. Int J Cancer, 1977, 20: 680-688. doi: 10.1002/ijc.2910200506 [18] Kabalin JN, McNeal JE, Price HM, et al. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations[J]. J Urol, 1989, 141: 1091-1094. doi: 10.1016/S0022-5347(17)41178-5 [19] Takashima R, Egawa S, Kuwao S, et al. Anterior distribution of Stage T1c nonpalpable tumors in radical prostatectomy specimens[J]. Urology, 2002, 59: 692-697. doi: 10.1016/S0090-4295(02)01525-X